Top Verdicts
Feb. 16, 2017
Top Defense Verdict: Lewert v. Boiron USA Inc.
See more on Top Defense Verdict: Lewert v. Boiron USA Inc.
The plaintiffs in this consumer class action sought $10 million for claiming that France-based homeopathic medicine maker Boiron's flu-relief drug Oscillococcinum is merely a sugar pill and that the company misrepresented its health benefits. That allegedly violated California's Unfair Competition Law and the Consumer Legal Remedies Act.
At first, Orrick, Herrington & Sutcliffe LLP appeared to face a daunting task in defe...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In